L1CAM Proteins, Antibodies, cDNA Clones, ELISA Kits Research Reagents

All L1CAM reagents are produced in house and quality controlled, including 13 L1CAM Antibody, 2 L1CAM ELISA, 27 L1CAM Gene, 1 L1CAM Lysate, 1 L1CAM Protein, 2 L1CAM qPCR. All L1CAM reagents are ready to use.

L1CAM Protein (1)

    L1CAM Antibody (13)

      L1CAM ELISA 试剂盒(即用型)& ELISA 抗体对套装(非即用型)(2)

      L1CAM cDNA Clone (27)

      NM_024003.2

      克隆载体 cDNA 产品

      In lentiviral vector

      NM_000425.4

      In expression vector

      NM_008478.3

      克隆载体 cDNA 产品

      In lentiviral vector

      L1CAM Lysate (1)

        L1CAM 分子背景

        L1 cell adhesion molecule (L1CAM), also designated as CD171, is a cell adhesion receptor of the immunoglobulin superfamily, known for its roles in nerve cell function. While originally believed to be present only in brain cells, in recent years L1-CAM has been detected in other tissues, and in a variety of cancer cells, including some common types of human cancer. L1CAM interacts with a variety of ligands including axonin-1, CD9, neurocan and intergrins, and it has been revealed that the RGD motif in the sixth Ig domain of L1CAM is a binding site for integrins, thus important for nuclear signaling. Disruption of L1CAM function causes three X-linked neurological syndromes, i.e. hydrocephalus, MASA syndrome (mental retardation, aphasia, shuffling gait and adducted thumbs) and spastic paraplegia syndrome. Overexpression of L1CAM in normal and cancer cells increased motility, enhanced growth rate and promoted cell transformation and tumorigenicity. Recent work has identified L1CAM (CD171) as a novel marker for human carcinoma progression, and a candidate for anti-cancer therapy.

        L1CAM 参考文献

        • Meier F, et al. (2006) The adhesion molecule L1 (CD171) promotes melanoma progression. Int J Cancer. 119(3): 549-55.
        • Gavert N, et al. (2008) L1-CAM in cancerous tissues. Expert Opin Biol Ther. 8(11): 1749-57.
        • Issa Y, et al. (2009) Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration. J Mol Med. 87(1): 99-112.
        • Weidle UH, et al. (2009) L1-CAM as a target for treatment of cancer with monoclonal antibodies. Anticancer Res. 29(12): 4919-31.
        • Raveh S, et al. (2009) L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett. 282(2): 137-45.
        • Wolterink S, et al. (2010) Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma. Cancer Res. 70(6): 2504-15.

        Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.